Compounds > 5'-o-(((2-decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine
Page last updated: 2024-12-07

5'-o-(((2-decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5'-O-(((2-decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine: inhibits various membrane-associated UDP-glycosyltransferases; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132900
SCHEMBL ID14657088
MeSH IDM0217722

Synonyms (15)

Synonym
5'-o-(((2-decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine
149970-64-9
uridine, 5'-(((2-((1-oxodecyl)amino)-3-phenylpropoxy)carbonyl)sulfamate), (s)-
pp55
[2-(decanoylamino)-3-phenylpropyl] n-[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxysulfonyl]carbamate
6Q8QE18NHL ,
uridine, 5'-(((2-((1-oxodecyl)amino)-3-phenylpropoxy)carbonyl)sulfamate)
pp-55
165307-53-9
unii-6q8qe18nhl
SCHEMBL14657088
4-hydroxy-1-{5-o-[(hydroxy{2-[(1-hydroxydecylidene)amino]-3-phenylpropoxy}methylidene)sulfamoyl]pentofuranosyl}pyrimidin-2(1h)-one
DTXSID80933822
Q27265333
5/'-o-(((2-decanoylamino-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
uridine
[no description available]		3.0950uridinesdrug metabolite;
fundamental metabolite;
human metabolite
1-naphthol
1-naphthol: RN given refers to parent cpd. 1-naphthol : A naphthol carrying a hydroxy group at position 1.. hydroxynaphthalene : Any member of the class of naphthalenes that is naphthalene carrying one or more hydroxy groups.		1.9810naphtholgenotoxin;
human xenobiotic metabolite
uridine diphosphate glucose
Uridine Diphosphate Glucose: A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids.. UDP-alpha-D-glucose : The alpha-anomer of UDP-alpha-D-glucose. It is used in nucleotide sugars metabolism.		1.9810UDP-D-glucosefundamental metabolite
2-naphthol
2-naphthol: RN given refers to parent cpd. 2-naphthol : A naphthol carrying a hydroxy group at position 2.. naphthols : Any hydroxynaphthalene derivative that has a single hydroxy substituent.		1.9810naphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
deoxyuridine
[no description available]		2.6830pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pp36
5'-((N-(2-decanoylamino-3-hydroxy-3-phenylpropyloxycarbonyl)glycyl)amino)-5'-deoxyuridine: inhibits various membrane-associated UDP-glycosyltransferases; structure given in first source		2.6830
hymecromone
Hymecromone: A coumarin derivative possessing properties as a spasmolytic, choleretic and light-protective agent. It is also used in ANALYTICAL CHEMISTRY TECHNIQUES for the determination of NITRIC ACID.		1.9810hydroxycoumarinantineoplastic agent;
hyaluronic acid synthesis inhibitor
glycolipids
[no description available]		2.3920
transforming growth factor alpha
Transforming Growth Factor alpha: An EPIDERMAL GROWTH FACTOR related protein that is found in a variety of tissues including EPITHELIUM, and maternal DECIDUA. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form which binds to the EGF RECEPTOR.		1.9910
ConditionIndicatedRelationship StrengthStudiesTrials
Germinoblastoma
[description not available]		01.9810
Lymphoma
A general term for various neoplastic diseases of the lymphoid tissue.		01.9810
Aging
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.		01.9910